Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kin Meds vs Measured

Kin Meds
Graded #75

Lower grade

vs+1.8999999999999915
Measured
Graded #61

Higher grade

The verdict

Measured takes it — 74.8/100 to 72.9/100, but only just.

Measured grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care. Kin Meds is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMeasured +11
74
85
Dose & formulationKin Meds +16
93
77
Clinical oversightMeasured +13
74
87
Labs & monitoringMeasured +10
53
63
FulfillmentKin Meds +5
72
67
Contract termsKin Meds +14
55
41
Kin Meds · left barMeasured · right bar

The numbers

MetricKin MedsMeasured
WeighScore72.9/10074.8/100
GradeCC
Scorecard rank#75#61
Semaglutide$149/mo (brand Wegovy)$119/mo (compounded)
Tirzepatide$149/mo (brand Zepbound)$229/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Kin Meds

Graded #75 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described
Measured

Graded #61 · C

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

Where it loses points

  • Membership ($49/mo) is billed separately on top of medication cost
  • Compounded medications are not FDA-approved
  • Compounding/dispensing pharmacies not individually named
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard